In the global healthcare landscape, heparins remain indispensable for preventing and treating life-threatening blood clots—from supporting post-surgical patients to managing conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE). As demand for reliable, high-purity heparins grows, healthcare brands, pharmaceutical distributors, and research institutions need a manufacturing partner that combines technical expertise, strict quality control, and global regulatory compliance. Jiulong, a leading Heparins Manufacturer, stands out in this critical space, delivering a comprehensive range of heparin products tailored to diverse clinical and industrial needs.
Comprehensive Heparin Product Portfolio
Unlike manufacturers focused on a single heparin type, Jiulong offers a full spectrum of heparin-based solutions to address varied market demands. Our core products include unfractionated heparin (UFH)—ideal for inpatient settings like cardiac surgeries, where rapid anticoagulation and reversibility are critical—and low molecular weight heparins (LMWHs) such as enoxaparin and dalteparin, which are preferred for outpatient prophylaxis due to their longer half-life and reduced bleeding risk. Each product is formulated to meet specific application requirements: for example, our pharmaceutical-grade UFH adheres to the strictest potency standards for injectable use, while our bulk heparin sodium is optimized for use in diagnostic reagents and research applications. This versatility makes Jiulong a one-stop partner for clients across the healthcare value chain.
Advanced Manufacturing & Purity Assurance
As a dedicated Heparins Manufacturer, Jiulong invests heavily in cutting-edge production technology to ensure consistency and purity. Our manufacturing process begins with ethically sourced, traceable raw materials—we partner with verified suppliers to obtain high-quality porcine intestinal mucosa, the gold standard for heparin production, and implement full-chain traceability systems to track materials from source to finished product. Using advanced enzymatic extraction and ultrafiltration techniques, we remove impurities while preserving the bioactive structure of heparin chains. Critical steps like depolymerization (for LMWH production) are controlled via automated systems to ensure uniform molecular weight distribution, a key factor in heparin efficacy and safety.
Every batch of heparin undergoes rigorous testing in our GMP-certified laboratories. We conduct assays for potency (using USP/EP reference standards), endotoxin levels (to prevent febrile reactions), and contaminant detection—including tests for heavy metals and residual solvents. Our heparins consistently meet or exceed international pharmacopeial standards (USP, EP, JP), ensuring they are safe for use in global markets. This commitment to purity has earned Jiulong the trust of clients in regions with strict regulatory requirements, from North America to the European Union.
Regulatory Expertise & Client Support
Navigating the complex regulatory landscape for heparins is a challenge for many clients—and Jiulong’s regulatory team acts as a strategic partner to simplify this process. We provide comprehensive documentation packages, including Certificate of Analysis (CoA), Drug Master File (DMF) submissions, and compliance reports, to support clients’ regulatory filings in their target markets. For emerging markets, our team offers guidance on local registration requirements, helping clients accelerate time-to-market.
Beyond compliance, we offer tailored technical support to ensure clients maximize the value of our heparins. For pharmaceutical manufacturers, our scientists provide formulation advice—such as optimizing heparin stability in pre-filled syringes—while for supplement brands, we share insights on dosage form development (e.g., oral heparin for gut health applications). We also maintain a dedicated customer service team to handle order inquiries, provide real-time production updates, and address post-delivery support needs, ensuring a seamless partnership experience.
Competitive Supply Chain & Sustainability
As a Heparins Manufacturer, Jiulong understands that timely delivery is critical for healthcare clients. Our scalable production facilities have an annual capacity of 500,000 API units, allowing us to fulfill both small-batch orders (for specialty research) and large-volume contracts (for pharmaceutical giants) without compromising lead times. We also prioritize sustainability: our manufacturing processes reduce water and energy consumption, and we implement waste-recycling programs to minimize environmental impact—aligning with the sustainability goals of modern healthcare organizations.
For businesses seeking a reliable, innovative Heparins Manufacturer, Jiulong combines technical excellence, product diversity, and client-centric support. Whether you need bulk heparin for manufacturing, finished dosage forms for clinical use, or regulatory guidance to enter new markets, we have the expertise to meet your needs. Contact Jiulong today to discuss your heparin requirements and discover how our solutions can support your success in the global antithrombotic market.